Papers
1
Total Citations
3
H-Index
1
About
Amer Durrani is a leading surgical oncologist whose research focuses on refining minimally invasive techniques in melanoma surgery, particularly through robotic-assisted approaches. His major contribution lies in demonstrating that robot-assisted pelvic lymph node dissection (rPLND) for enlarged nodes in melanoma patients offers faster recovery and reduced morbidity while maintaining oncological outcomes equivalent to traditional open surgery. This work, published in 2024, has already garnered 3 citations, signaling its growing influence in the field. Durrani’s research addresses a critical gap: as systemic therapies evolve, the role of surgery in melanoma is shifting, and his findings provide evidence that robotic techniques can safely integrate into modern treatment paradigms. By prioritizing patient recovery without compromising cancer control, his work has practical implications for surgical decision-making. Durrani’s contributions are particularly notable for their focus on optimizing outcomes in a patient population with complex needs, positioning him as a key voice in the advancement of robotic surgery for melanoma.
Research Focus
Key Achievements
Top Papers
- 1